P/F Bakkafrost logo

BAKKAo - P/F Bakkafrost News Story

NOK731.2 0.0  0.0%

Last Trade - 07/05/21

Sector
Consumer Defensives
Size
Large Cap
Market Cap £3.53bn
Enterprise Value £3.80bn
Revenue £529.9m
Position in Universe 163rd / 1832

NORDIC STOCKS - Factors to watch on Aug 23

Tue 23rd August, 2016 6:57am
The following stocks may be affected by newspaper reports and 
other factors on Tuesday: 
     
    BAKKAFROST  BAKKA.OL  
    The Faroese fish farmer reported second-quarter operating 
profit below expectations on Tuesday, but kept its production 
guidance as it said it expected a tight market throughout 2016. 
    For more on the company, click on  BAKKA.OL  
     
    GENMAB  GEN.CO  
    The Danish biotech's CEO, Jan van de Winkel, will spend the 
next three to four years to identify the firm's next clear 
winner, he told daily Borsen. 
    The company has taken new drugs to the market twice and 
Winkel believes the next winner already is in the firm's 
pipeline. 
    For more on the company, click on  GEN.CO     
 
    ** For a summary of upcoming results and forecasts, double 
click on  NORD/EQTY  
    ** For the western European company diary covering earnings, 
shareholder meetings, news conferences and analysts' meetings, 
click on  WEU/EQUITY  or type in the code and hit the f9 button. 
    ** Double click on  0#.INDEX.ST  for Swedish indices, 
 0#.INDEX.CO  for Danish indices,  0#.INDEX.HE  for Finnish 
indices and  0#.INDEX.OL  for Norwegian indices 
    ** For real-time moves on Nordic blue-chip indices double 
click on  .OMXS30 ,  .OMXH25 ,  .OMXC20CAP  and  .OBX  
    ** For constituent stock moves highlight the above codes in 
the command box and press the f3 button on your keyboard 
    ** For Nordic top news items, double click on  TOP/NORD  
    ** For the latest news on Nordic stock price moves double 
click on  HOT-NORD-RTRS  
    (Reporting by Copenhagen, Oslo, Helsinki and Stockholm 
newsrooms) 
 
 
Keywords: NORDICS MARKETS/FACTORS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.